Atrial Tachycardia is a cardiac arrhythmia characterized by a rapid heartbeat originating in the atria, the upper chambers of the heart. Unlike normal heartbeats that are regulated by the sinoatrial (SA) node, individuals with atrial tachycardia experience an abnormal firing of electrical signals from within the atria, leading to a faster heart rate than the typical range of 60 to 100 beats per minute. This condition can be episodic or sustained, causing symptoms such as palpitations, shortness of breath, and dizziness. Diagnosis often involves the use of electrocardiograms (ECGs) to detect the rapid heart rhythm. Management strategies may include medications to control the heart rate, radiofrequency ablation to eliminate the abnormal electrical pathways, or, in severe cases, implantation of a pacemaker. A comprehensive understanding of the underlying causes, risk factors, and available treatment options is crucial for healthcare professionals to effectively manage and improve the quality of life for individuals with atrial tachycardia.
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India